Warby Parker Inc.
$25.89
▼
-5.23%
2026-04-21 10:18:00
www.warbyparker.com
NYQ: WRBY
Explore Warby Parker Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.1 B
Current Price
$25.89
52W High / Low
$31 / $13.63
Stock P/E
1,889.51
Book Value
$3
Dividend Yield
—
ROCE
-0.93%
ROE
0.46%
Face Value
—
EPS
$0.01
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
2,275
Beta
2.08
Debt / Equity
63.4
Current Ratio
2.35
Quick Ratio
2.05
Forward P/E
30.83
Price / Sales
2.92
Enterprise Value
$2.5 B
EV / EBITDA
54.86
EV / Revenue
2.86
Rating
Buy
Target Price
$29.17
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cuprina Holdings (Cayman) Limited | $0.33 | — | $2.47 M | — | 34.48% | -1.39% | $9.5 / $0.28 | $0.28 |
| 2. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 3. | Pulse Biosciences, Inc. | $23.73 | — | $1.61 B | — | -88.83% | -74.45% | $26.3 / $12.56 | $1.19 |
| 4. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
| 5. | Envista Holdings Corporation | $27.85 | 97.1 | $4.56 B | — | 4.89% | 1.56% | $30.42 / $14.72 | $18.96 |
| 6. | Hologic, Inc. | NOT FOUND | — | — | — | 9.77% | 10.86% | $76.07 / $51.9 | $23.51 |
| 7. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 211.97 M | 221.68 M | 214.47 M | 223.78 M | 190.64 M | — |
| Operating Profit | -6.85 M | 3.57 M | -4.53 M | 2.47 M | -9.42 M | — |
| Net Profit | -5.95 M | 5.87 M | -1.75 M | 3.47 M | -6.88 M | — |
| EPS in Rs | -0.06 | 0.06 | -0.02 | 0.03 | -0.06 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 871.9 M | 771.32 M | 669.76 M | 598.11 M |
| Operating Profit | -5.34 M | -30.11 M | -72 M | -111.2 M |
| Net Profit | 1.64 M | -20.39 M | -63.2 M | -110.39 M |
| EPS in Rs | 0.02 | -0.19 | -0.59 | -1.03 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 720.92 M | 676.49 M | 580.31 M | 568.71 M |
| Total Liabilities | 353.19 M | 336.42 M | 278.52 M | 282.06 M |
| Equity | 367.73 M | 340.07 M | 301.79 M | 286.65 M |
| Current Assets | 352.44 M | 326.05 M | 298.62 M | 294.57 M |
| Current Liabilities | 150.13 M | 130.35 M | 127.09 M | 129.56 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 110.78 M | 98.74 M | 60.99 M | 10.37 M |
| Investing CF | -67.05 M | -66.03 M | -54.67 M | -60.18 M |
| Financing CF | -12 M | 4.96 M | 2.87 M | 3.29 M |
| Free CF | 43.74 M | 34.71 M | 7.32 M | -49.81 M |
| Capex | -67.05 M | -64.03 M | -53.67 M | -60.18 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 15.16% | 11.98% | — | — |
| Earnings Growth % | 67.74% | 42.75% | — | — |
| Profit Margin % | -2.64% | -9.44% | -18.46% | — |
| Operating Margin % | -3.9% | -10.75% | -18.59% | — |
| Gross Margin % | 55.34% | 54.53% | 57.02% | — |
| EBITDA Margin % | 2.04% | -4.99% | -13.26% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.